Johnson & Johnson News
Gilead's Sofosbuvir under European Review - Analyst Blog
Zacks 5:25 PMGilead's sofosbuvir is under review in Europe.
Is There Growth Left in Massive Drug Stocks?
Fool 12:10 PMIs There Growth Left in Massive Drug Stocks?
Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow
7:00 AMThursday, May 23, 2013 is the ex-dividend date for Dow component (NYSE:JNJ).
5 Stocks Going Ex-Dividend Tomorrow: SMG, FMER, AIZ, KEY, JNJ
6:00 AMSMG FMER AIZ KEY JNJ are going ex-dividend tomorrow, May 23, 2013
The Long Case For 3M
5:32 AMStock Market News for May 22, 2013 - Market News
Zacks 5:06 AMBenchmarks eked out gains after a Federal Reserve official clarified doubt on monetary stimulus on Tuesday
Allocate Assets to Buy-Rated Dow Stocks
4:50 AMThese 15 buy-rated DJIA components provide a diversified portfolio of stocks.
The Surprising Link Between ADHD and Obesity
Fool May 21This disorder in childhood could put your adult health at risk.
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| JNJ | 88.34 | -0.25 | -0.28% | 248.14B |
New watchlist
